Lansap and disseminated intravascular coagulation Patient Reports February 12, 2012

Lansap Side Effects Report #5472498-1
Lansap side effect was reported by a Consumer or non-health professional from JAPAN on Sept 25, 2007. Male patient, 48 years of age, was diagnosed with helicobacter infection and was treated with Lansap. After drug was administered, patient experienced the following side effects: diarrhoea, disseminated intravascular coagulation, pyrexia. Lansap dosage: unknown. Patient was hospitalized. Patient recovered.

Lansap Side Effects Report #5491373-X
Lansap side effect was reported by a Consumer or non-health professional from JAPAN on Oct 15, 2007. Male patient, 48 years of age, was diagnosed with helicobacter infection and was treated with Lansap. After drug was administered, patient experienced the following side effects: diarrhoea, disseminated intravascular coagulation, lymphoma , pyrexia. Lansap dosage: unknown. Patient was hospitalized. Patient recovered.

Lansap Side Effects Report #5741425-1
Lansap side effect was reported by a Consumer or non-health professional from JAPAN on May 07, 2008. Male patient, 62 years of age, was diagnosed with gastric ulcer, helicobacter infection and was treated with Lansap. After drug was administered, patient experienced the following side effects: blood pressure decreased, c-reactive protein increased, depressed level of consciousness, diarrhoea, disseminated intravascular coagulation, enterocolitis, gastroenteritis staphylococcal, haemodialysis, immunosuppression. Lansap dosage: unknown. During the same period patient was treated with NU LOTAN, SELBEX, THYRADIN S, ENTERONON, TANATRIL, CALTAN. Patient died.

Lansap Side Effects Report #5748812-6
Lansap side effect was reported by a Consumer or non-health professional from JAPAN on May 07, 2008. Male patient, 62 years of age, was diagnosed with gastric ulcer, helicobacter infection and was treated with Lansap. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood bilirubin increased, blood creatine phosphokinase increased, blood lactate dehydrogenase increased, depressed level of consciousness, disseminated intravascular coagulation, gastroenteritis staphylococcal, hypovolaemic shock. Lansap dosage: unknown. During the same period patient was treated with NU LOTAN, SELBEX, THYRADIN, ENTERONON, TANATRIL, CALTAN. Patient was hospitalized. Patient died.


Lansap Side Effects Report #5818327-5
Lansap side effect was reported by a Physician from JAPAN on July 10, 2008. Male patient, 62 years of age, weighting 136.7 lb, was diagnosed with gastric ulcer, helicobacter infection and was treated with Lansap. After drug was administered, patient experienced the following side effects: activated partial thromboplastin time prolonged, alanine aminotransferase increased, aspartate aminotransferase increased, blood creatine phosphokinase increased, blood lactate dehydrogenase increased, depressed level of consciousness, disseminated intravascular coagulation, dyspnoea, gamma-glutamyltransferase increased. Lansap dosage: unknown. During the same period patient was treated with NU LOTAN, SELBEX, LEVOTHYROXINE, ENTERONON, TANTARIL, CALTAN. Patient was hospitalized. Patient died.